Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.92253 | 65 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.84392 | 64 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.83604 | 64 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.71402 | 62 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.82469 | 64 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.03273 | 66 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.84641 | 63 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.82054 | 64 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.81582 | 64 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.83136 | 64 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.82675 | 64 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.81847 | 64 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.7676 | 63 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.83132 | 64 |